banner
Home / Products / Anti-tumor
Products
Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Overview Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Su
Basic Info
Model NO. D-sung Vincristine Sulfate
Product Name Vincristine Sulfate
Name Vincristine Sulfate Powder
CAS No. 2068-78-2
Appearance White Powder
Color White
Grade Pharmaceutical Grade
Assay HPLC 99%
Application Pharmaceutical
Specific COA
Test Method HPLC
Shelf Life 2 Years
Mf C46h58n4o14s
Einecs 218-190-0
Melting Point 300 C
Storage Temperature 2-8ºC
Transport Package Negotiable
Specification 99%
Trademark D-sung
Origin Shaanxi Xi′an
Production Capacity 1000kg/Month
Product Description

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Product Description

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Product Details

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

Product NameVincristine Sulfate
AppearanceWhite Powder
CAS No.2068-78-2
MFC46H58N4O14S

Vincristine sulfate, also known as vincristine sulfate, is an organic compound with the chemical formula C46H58N4O14S, mainly used in biochemical and tumor research.

Application&Function

Pharmaceutical Grade CAS 2068-78-2 Vincristine Sulfate Anti-Tumor Vincristine Sulfate Raw Powder Vincristine Sulphate

indication1. Acute leukemia, especially childhood acute leukemia, has a significant therapeutic effect on acute lymphocytic leukemia.2. Malignant lymphoma.3. Germ cell tumors.4. Small cell lung cancer, Ewing's sarcoma, nephroblastoma, neuroblastoma.5. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma and multiple myeloma.

Specification